Clinical trials for Schizophrenia

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Schizophrenia. For all clinical trials, go to clinical trials search

This list shows clinical trials for Schizophrenia

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Schizophrenia
Title Recruitment status Location
European Long-acting Antipsychotics in Schizophrenia Trial Recruiting United Kingdom
A Non-Interventional Prospective Cohort Study of Patients With Persistent Symptoms of Schizophrenia to Describe The Course and Burden of Illness Recruiting United Kingdom
Early versus late initiation of treatment with Risperdal Consta in subjects with schizophrenia or schizoaffective disorder after an acute episode - Risperdal long acting injections after acute psychosis Not Recruiting United Kingdom
A 6-month, open label, prospective, multicenter, international, exploratory study of a transition to flexibly dosed paliperidone palmitate in patients with schizophrenia previously unsuccessfully treated with oral or long-acting injectable antipsychotics. - PALMFlexS Not Recruiting United Kingdom
A 24-month, Prospective, Randomized, Active-Controlled, Open-Label, Rater Blinded, Multicenter, International Study of the Prevention of Relapse Comparing Long-Acting Injectable Paliperidone Palmitate to Treatment as Usual with Oral Antipsychotics Monotherapy in Adults With Schizophrenia. Not Recruiting United Kingdom
A multicenter, double- blind, flexible-dose, 6-month extension trial comparing the safety and efficacy of asenapine with olanzapine in subjects who completed Protocol 25543 . Not Recruiting United Kingdom
A 6-month, open label, prospective, multicenter, international, exploratory study of a transition to flexibly dosed paliperidone palmitate in patients with schizophrenia previously unsuccessfully treated with oral or long-acting injectable antipsychotics. - PALMFlexS Not Recruiting United Kingdom
A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Evaluate the Safety and Tolerability of Paliperidone ER and Olanzapine in Subjects with Schizophrenia - ND Not Recruiting United Kingdom
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients with Schizophrenia "ASPIRE OPEN-LABEL" (Aripiprazole Intramuscular Depot Progam in Schizophrenia) - ASPIRE OPEN-LABEL Not Recruiting United Kingdom
Early versus late initiation of treatment with Risperdal Consta in subjects with schizophrenia or schizoaffective disorder after an acute episode - Risperdal long acting injections after acute psychosis Not Recruiting United Kingdom

Page last reviewed:

Next review due: